Europe
BC Platforms announced that it has formed a collaboration with Debiopharm, a Swiss pharmaceutical company, to deliver a complete clinical and genomic data management solution to support its innovative oncology pipeline, including investigational product programs for Debio 0123, diagnostic molecular screening for Debio 1347 and clinical exploratory results for Debio 1143.
GENFIT announced that Dr. Carol L. Addy has joined the Company as Chief Medical Officer.
4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final close
Former Principal at Wellington Partners Life Sciences appointed to drive Fund’s European investments
BerGenBio ASA presents study updates from its Phase II clinical development programme with bemcentinib, a first-in-class highly selective oral AXL inhibitor, in non-small cell lung cancer at the 2019 World Conference on Lung Cancer in Barcelona, Spain.
ADC Therapeutics SA announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common shares.
Soricimed Biopharma Inc. announced that it has entered into a strategic alliance with Image Analysis Group, a UK-based company with unique expertise in medical imaging and artificial intelligence-based image analytics, whereby the companies will join their efforts in the development of Soricimed’s lead anti-cancer drug candidate, SOR-C13, a first-in-class inhibitor of the TRPV6 calcium channel.
To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM
Evanescent Acoustic Beam Moves Suspended Particles at Lower Cost & Energy Consumption Than Existing Propagative Surface Acoustic Wave (SAW) Systems
Martinsried/ Munich Medigene AG announced its participation at the following upcoming scientific and investor conferences.
PRESS RELEASES